Abstract
Purpose: Papillary thyroid carcinomas (PTC) less than 2 cm in size are believed to be a less aggressive subset of PTC which behave more like benign lesions and are often more conservatively treated. However, it is unclear whether carcinoma no larger than 2.0 cm in diameter can be expected to have a similar favorable clinical behavior as tumors no larger than 1.0 cm. Therefore, to address this question and to characterize the biology and optimal treatment for PTC less than 2 cm, we performed a retrospective chart review. Methods: From October 2001 to March 2013, 649 patients underwent surgery for PTC less than 2 cm. Data from these patients were retrospectively analyzed. Results: The mean age of these patients was 43.2 years and 91.7% were female. 52.9% of the patients underwent a total or near-total thyroidectomy. Of the 649 patients, 2196 (30.2%) had lymph node metastases. The patients present with signs of aggressiveness including multifocality (42.5%), bilaterality (24.3%), capsular invasion (44.5%). Lymph node metastases were associated with tumor size (p=0.008) only, but not capsular invasion, bilaterality, multifocality, age and sex. With follow-up of up to 138 months, 7 patients had a local recurrence (recurrence rate=1.1%), 2 patients had a distant metastasis. No patients have died during this period. Conclusion: In PTC less than 2 cm in size, progressively increasing frequency of signs of tumor aggressiveness including bilaterality, capsular invasion and lymph node metastasis with increasing tumor size.
Highlights
Papillary thyroid carcinoma (PTC) represents the most prevalent type of thyroid carcinoma, with 85-90% of new cases of all thyroid carcinomas and less than 10% in mortality [1]
With the development in thyroid ultrasonography (USG) and USG-guided FNA, thyroid carcinoma tends to be detected at an earlier stage and in particular, detection and treatment of micropapillary carcinoma no larger than 1.0 cm in diameter becomes outstanding, and many studies have shown that papillary thyroid microcarcinoma (PTMC) has a more favorable clinical behavior than large papillary carcinoma [2,3]
The analysis of PTC depending on its size of
Summary
Papillary thyroid carcinoma (PTC) represents the most prevalent type of thyroid carcinoma, with 85-90% of new cases of all thyroid carcinomas and less than 10% in mortality [1]. With the development in thyroid ultrasonography (USG) and USG-guided FNA, thyroid carcinoma tends to be detected at an earlier stage and in particular, detection and treatment of micropapillary carcinoma no larger than 1.0 cm in diameter becomes outstanding, and many studies have shown that papillary thyroid microcarcinoma (PTMC) has a more favorable clinical behavior than large papillary carcinoma [2,3]. The question here is whether PTMC
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.